穴位贴敷联合吲哚美辛呋喃唑酮栓在混合痔术后镇痛的临床观察

Clinical Observation of Acupoint Application Combined with Indomethacin and Furazolidone Suppository for Postoperative Pain Relief in Mixed Hemorrhoids

摘要: 目的：观察穴位贴敷联合吲哚美辛呋喃唑酮栓治疗混合痔术后肛门疼痛的临床疗效。方法：随机选择2022年10月至2024年10月我科收治的混合痔外剥内扎术后患者60例，按照随机数字表法分为治疗组和对照组，每组样本容量30例，对照组采用吲哚美辛呋喃唑酮栓治疗，治疗组在对照组的基础上给予穴位贴敷治疗，疗程为1周，比较两组患者的肛门疼痛评分及临床疗效。结果：治疗组在术后6 h、24 h、48 h、第7天各时间点的VAS评分均低于对照组，差异有统计学意义(P < 0.05)，两组患者术前30 min、术后2 h的VAS评分差异不具有统计学意义(P > 0.05)；治疗组的总有效率大于对照组，差异有统计学意义(P < 0.05)；治疗组与对照组的不良反应发生率差异无统计学意义(P > 0.05)。结论：穴位贴敷联合吲哚美辛呋喃唑酮栓治疗混合痔术后肛门疼痛具有更好的临床疗效，值得临床推广应用。

Abstract: Objective: To observe the clinical efficacy of acupoint application combined with indomethacin and furazolidone suppositories in the treatment of postoperative anal pain after mixed hemorrhoid surgery. Methods: A total of 60 patients with postoperative anal pain after mixed hemorrhoid surgery admitted to our department from October 2022 to October 2024 were randomly selected and divided into a treatment group and a control group using a random number table, with 30 cases in each group. The control group was treated with indomethacin and furazolidone suppositories, while the treatment group received acupoint application in addition to the treatment given to the control group. The treatment course was 1 week. The anal pain scores and clinical efficacy were compared between the two groups. Results: The VAS scores of the treatment group at 6 hours, 24 hours, 48 hours, and 7 days postoperatively were significantly lower than those of the control group (P < 0.05). There was no significant difference in VAS scores between the two groups at 30 minutes preoperatively and 2 hours postoperatively (P > 0.05). The overall effective rate of the treatment group was higher than that of the control group, with a statistically significant difference (P < 0.05). There was no significant difference in the incidence of adverse reactions between the treatment and control groups (P > 0.05). Conclusion: Acupoint application combined with indomethacin and furazolidone suppositories shows better clinical efficacy in the treatment of postoperative anal pain after mixed hemorrhoid surgery and is worthy of clinical application and promotion.